Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Optically Active Nitro Compounds. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Efficient asymmetric Michael addition for pharmaceutical intermediates using novel Ru-diamine complexes. Reduces cost and improves purity for API manufacturing.
Patent CN1626501A details a high-efficiency ruthenium-catalyzed asymmetric Michael addition for producing optically active nitro and cyano compounds, offering significant cost reduction in API manufacturing.